Bone marrow metastasis in primary bronchial mucoepidermoid carcinoma: a case report
© Pan et al.; licensee BioMed Central Ltd. 2014
Received: 3 September 2013
Accepted: 9 May 2014
Published: 21 May 2014
Primary bronchial mucoepidermoid carcinoma in the lung is relatively rare. It rarely presents with the highly malignant biological characteristic of bone marrow metastasis. We describe a case of this disease with bone marrow metastasis. A 56-year-old man with the primary manifestation of bone pain and bloodstained sputum had two abnormal shadows on the left inferior lobar bronchus and peripheral tissue of the lower lobe of the left lung, respectively. Computed tomography-guided percutaneous puncture biopsy and bone imaging confirmed the diagnosis of high-grade bronchial mucoepidermoid carcinoma with bone metastasis. However, the patient soon presented with progressive hemoglobin and platelet decline and severe multi-organ hemorrhage. Subsequently, we performed bone marrow aspiration and biopsy, which revealed malignant cells and necrosis. The patient deteriorated rapidly from the disease, and died on the 16th day of admission. We hope that this case report will increase awareness of the possibility of primary high-grade bronchial mucoepidermoid carcinoma metastasizing to the bone marrow, which might be a poor prognostic factor.
KeywordsMucoepidermoid carcinoma Lung Bone marrow metastasis
Primary bronchial mucoepidermoid carcinoma, a low-malignant potential tumor of bronchial gland origin, is relatively rare and comprises approximately 0.1% of all malignant lung tumors . Compared with most other lung cancers, it occurs in relatively young people [2–4]. Although mucoepidermoid carcinomas are malignant tumors, they are usually indolent, with chronic progression. Surgical treatment yields a favorable prognosis; the 5-year survival rate is 95% and adjuvant treatment is considered unnecessary. Mucoepidermoid carcinomas rarely present highly malignant biological characteristics, especially bone marrow metastasis. We report a case of unusually aggressive bronchial mucoepidermoid carcinoma with bone marrow metastasis with the aim of raising awareness of the malignant biological behavior of this tumor.
Laboratory test results
6 days after admission
8 days after admission
Based on its histopathological features, we diagnosed the present lung tumor as primary high-grade bronchial mucoepidermoid carcinoma, which is relatively rare in the lung. Histologically, it is believed that mucoepidermoid carcinomas are derived from the serous and mucus glands of the trachea and bronchi. They are classified as low or high grade according to histological appearance, cellular atypia, mitotic activity, local invasion, and necrosis. It is believed that the biological behavior is associated with differentiation . The prognosis of low-grade mucoepidermoid carcinomas is much better. Only very few cases of high-grade tumors with the malignant features of rapid deterioration and early distant metastases have extremely poor prognosis .
Bronchial mucoepidermoid carcinoma always occurs in the central bronchi. It appears on CT as an isolated, well-defined oval or lobulated mass with smooth margins arising within the bronchus . It may be associated with obstructive pneumonia and atelectasis, or in a few cases, with cavitation and calcification. On CT imaging, the majority of these tumors exhibits moderate to marked enhancement. However, the present tumor was mainly located in the left inferior lobar bronchus and associated with an oval, spiculated mass in the peripheral lung tissue, a multicenter origin considered very rare.
Poorly differentiated bronchial mucoepidermoid carcinoma may present with the highly malignant biological characteristics of regional lymph node metastases. However, distant metastases, especially bone marrow metastasis, are extremely rare, and have not been reported in the available literature. Bone marrow metastasis occurs when cancer cells from a non-hematological tumor infiltrate the bone marrow via hematogenous spread or direct extension from contiguous tumor deposits . Malignant cells in bone marrow smears and biopsy are a key diagnostic feature. Patients typically present with anemia, bone pain, fatigue, and progressive deterioration. Changes in the peripheral blood are always obvious decreased HGB and PLT, but normal or increased leukocytes .
Metastatic carcinoma in bone marrow in the exhaustion phase is a rare pathophysiological form of bone marrow metastasis. Featuring rapid onset, progressive anemia, and thrombocytopenia accompanied by severe hemorrhage, infection, and even disseminated intravascular coagulation (DIC), it is considered a lethal complication of malignant tumor [8–10]. Due to the poor performance status, systemic chemotherapy is often considered a relative contraindication for such patients. Thus, the duration of survival maintained by only supportive treatment is usually very limited .
The diagnosis of bone marrow metastasis in our patient was based on bone marrow smear and biopsy. The abnormal laboratory test parameters (prolonged prothrombin time and activated partial thromboplastin time, decreased fibrinogen, elevated D-dimer level) supported the diagnosis of DIC. All clinical features and auxiliary examinations were consistent with bone marrow failure induced by metastatic carcinoma. Regrettably, we were unable to perform the bone marrow examination in time and administer salvage chemotherapy to this patient in view of his personal wishes and rapid deterioration from the disease.
This case demonstrates the ability of primary high-grade bronchial mucoepidermoid carcinoma to metastasize to the bone marrow, which, as has been the case in many other tumors, might be a poor prognostic factor in mucoepidermoid carcinoma. Thus, we suggest considering the probability of bone marrow metastasis if there is progressive PLT and HGB decline without any obvious reason. Bone marrow aspiration and biopsy should be performed to confirm diagnosis as soon as possible. Regardless, timely salvage chemotherapy may prolong survival and improve the prognosis.
We obtained written informed consent from the next of kin of the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Zhenyu Pan and Guozi Yang are co-first authors.
We thank Dr. Hongguang Zhao for her expert technical assistance about bone scintigraphy.
- Leonardi HK, Jung-Legg Y, Legg MA, Neptune WB: Tracheobronchial mucoepidermoid carcinoma. J Thorac Cardiovasc Surg. 1978, 76: 431-438.PubMedGoogle Scholar
- Yousem S, Nicholson A: Mucoepidermoid carcinoma. World Health Organization classification of tumours.Pathology and genetics of tumours of the lung, pleura, thymus and heart. Edited by: Travis W, Brambilla E, Muller-Hermlink H, Harris C. 2004, Lyon: IARC, 63-64.Google Scholar
- Liu X, Adams AL: Mucoepidermoid carcinoma of the bronchus: a review. Arch Pathol Lab Med. 2007, 131: 1400-1404.PubMedGoogle Scholar
- Hashemzade S, Taghizadieh A, Rashidi F, Esmaeili HA, Mohammadreza G: Mucoepidermoid carcinoma of trachea in a 22 years old woman: a case report. Pneumologia. 2011, 60: 164-165.PubMedGoogle Scholar
- Yousem SA, Hochholzer L: Mucoepidermoid tumors of the lung. Cancer. 1987, 60: 1346-1352. 10.1002/1097-0142(19870915)60:6<1346::AID-CNCR2820600631>3.0.CO;2-0.View ArticlePubMedGoogle Scholar
- Shimizu J, Watanabe Y, Oda M, Morita K, Tsunezuka Y, Nonomura A: Clinicopathologic study of mucoepidermoid carcinoma of the lung. Int Surg. 1998, 83: 1-3.PubMedGoogle Scholar
- Li X, Zhang W, Wu X, Sun C, Chen M, Zeng Q: Mucoepidermoid carcinoma of the lung: common findings and unusual appearances on CT. Clin Imaging. 2012, 36: 8-13. 10.1016/j.clinimag.2011.03.003.View ArticlePubMedGoogle Scholar
- Xiao L, Luxi S, Ying T, Yizhi L, Lingyun W, Quan P: Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples. J Cancer Res Clin Oncol. 2009, 135: 687-693. 10.1007/s00432-008-0503-2.View ArticlePubMedGoogle Scholar
- Ozkan M, Er O, Karahan IO, Deniz K, Coşkun R, Küçük C, Yurci A, Altinbaş M: Rectal carcinoid tumor with bone marrow and osteoblastic bone metastasis: a case report. Turk J Gastroenterol. 2007, 18: 111-114.PubMedGoogle Scholar
- Krishnan C, George TI, Arber DA: Bone marrow metastases: a survey of nonhematologic metastases with immunohistochemical study of metastatic carcinomas. Appl Immunohistochem Mol Morphol. 2007, 15: 1-7. 10.1097/01.pai.0000213134.09160.14.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.